Carbogen Amcis company information, Employees & Contact Information

Celonic, Carbogen Amcis Partner to Offer Integrated ADC Development & Manufacturing Contract Pharma

CARBOGEN AMCIS Shanghai Site Awarded Drug Manufacturing License from Chinese NMPA GlobeNewswire

CARBOGEN AMCIS Secures GMP Certification After Successful ANSM Inspection for its Aseptic Drug Product Manufacturing Site BioSpace

CARBOGEN AMCIS investing 25 million francs to expand Aargau sites Switzerland Global Enterprise

Dishman Carbogen Amcis Limited Announces Postal Ballot Results TipRanks

Mark C. Griffiths Named Carbogen Amcis CEO CHEManager

Dishman Carbogen Amcis Subsidiary Forms Strategic Alliance with Celonic Group for Integrated ADC Platform scanx.trade

Dishman Carbogen Amcis Shows Positive Technical Trends Amid Market Evaluation Revision Markets Mojo

Carbogen Amcis Obtains Drug Manufacturing License from Chinese NMPA Contract Pharma

Private companies among Dishman Carbogen Amcis Limited's (NSE:DCAL) largest shareholders, saw gain in holdings value after stock jumped 14% last week simplywall.st

Dishman Carbogen Amcis reports standalone net loss of Rs 7.37 crore in the March 2025 quarter Business Standard

Carbogen Amcis appoints Stephan Fritschi as CEO Indian Pharma Post

Dishman Carbogen Amcis Shows Mixed Technical Trends Amid Strong Performance Resilience Markets Mojo

Dishman Carbogen Amcis Receives US FDA Approval for Naroda Facility scanx.trade

Dishman Carbogen Amcis (NSE:DCAL) jumps 14% this week, taking five-year gains to 180% simplywall.st

Dishman Carbogen Amcis Ltd Spikes 4.86% Business Standard

Dishman Carbogen Amcis Limited's (NSE:DCAL) Share Price Boosted 32% But Its Business Prospects Need A Lift Too simplywall.st

Dishman Carbogen Amcis Seeks Shareholder Approval for Capital Increase and Rs 1,000 Crore Fund Raise scanx.trade

Dishman Carbogen Amcis Achieves 52-Week High Amid Broader Market Decline Markets Mojo

Dishman Carbogen Amcis' Ahmedabad facility clears USFDA inspection without observations Business Standard

Dishman Carbogen Amcis announces of change in CEO of Carbogen Amcis entities Business Standard

Swiss CDMO Carbogen bolsters ADC production capability with $31M investment Fierce Pharma

Celonic and Carbogen Amcis Launch ADC Partnership Technology Networks

Women Leaders in Pharma Interview: Mara Guzzetti, General Manager, CARBOGEN AMCIS Switzerland DCAT Value Chain Insights

Carbogen Amcis Completes FDA Inspections at Two Manufacturing Sites Contract Pharma

CARBOGEN AMCIS Manchester wins prestigious Chemical Industry Award for world-class manufacturing Invest In Manchester

Two in ADC partnership Speciality Chemicals Magazine

Stocks to Watch Today: Wipro, NHPC, Dhani Services, Dishman Carbogen Amcis, Dhanlaxmi Bank in focus on 20... Moneycontrol

Swiss pharma manufacturing to expand with CHF 25.5 million investment Labmate Online

Dishman Carbogen Amcis Expands Swiss ADC Manufacturing with CHF 25M HDFC Sky

Should You Invest in Dishman Carbogen Amcis Limited Before Its Next Earnings Report - Trading Signal Analysis & Beginner Investor Opportunities To Watch Now Trung tâm Dự báo KTTV quốc gia

Dishman Carbogen Amcis opens $50 million new facility in France The Economic Times

Dishman Carbogen Amcis updates on inspection by EDQM and AIFA Indian Pharma Post

Carbogen Amcis AG signs co-investment agreement Indian Pharma Post

Dishman Carbogen Amcis Q3 FY23 revenue up 14% Indian Pharma Post

CARBOGEN AMCIS AG., has entered into a co-investment agreement of more than CHF 25 million with a key client to expand Swiss sites EquityBulls

India's Ab-drug-conjugate API manufacturer expands to Switzerland with CHF 15 M investment BioSpectrum Asia

Dishman Carbogen Amcis Faces Mixed Market Sentiment Amid Valuation Challenges Markets Mojo

Carbogen Amic AG to co-invest in its manufacturing sites in Switzerland Business Standard

Dishman Carbogen Amcis net revenue stands at Rs 541 crores for Q1 FY23 Business Standard

Dishman Carbogen Amcis Swings to Profit in Q4, Reports Strong Revenue Growth scanx.trade

Dishman Carbogen Amcis updates on USFDA inspection at its Bavla facility Indian Pharma Post

Dishman Carbogen Amcis Stock Soars 8.53%, Outperforms Sector and Sensex Markets Mojo

Dishman Carbogen Amcis Streamlines Operations: Merges Two Swiss Subsidiaries scanx.trade

CARBOGEN AMCIS SAS opens new manufacturing facility for sterile liquid drugs in France Express Pharma

Stocks to Watch Today: TCS, Biocon, GAIL, Greaves Cotton, Sun Pharma, Dishman Carbogen Amcis, Coromandel... Moneycontrol

Dishman Carbogen Amcis' Bavla unit clears USFDA audit Business Standard

Dishman Carbogen Amcis Reports Strong Revenue Growth and Improved Financial Position scanx.trade

Dishman Carbogen Amcis Boosts Authorized Share Capital by Rs. 3.95 Crores scanx.trade

Dishman Carbogen Amcis expects turnaround in FY22, working on resolution of regulatory issues at Bavla... Moneycontrol

Dishman Carbogen Amcis Shares Up More than 50% in Last 11 Trading Sessions Equitypandit

Dishman Carbogen Amcis - Mukul Agrawal added these 2 stocks to his portfolio in Q1, hiked stakes in 6 others The Economic Times

Dishman Carbogen Amcis Ltd consolidated Q3FY23 net profit up at Rs. 4.69 crores EquityBulls

Dishman Carbogen Amcis announces successful FDA inspection Express Pharma

Pharma Stock jumps 10% after company to manufacture in China after receiving Drug License Trade Brains

Buy Dishman Carbogen Amcis, target Rs 355: HDFC Securities The Economic Times

Dishman Pharma's Swiss arm Carbogen Amcis to expand operations Business Standard

Dishman Carbogen Amcis records 16 pc growth in Q1 net sales at Rs 551 crore ThePrint

Dishman Carbogen Amcis (₹162.7): Buy BusinessLine

Dishman Carbogen Amcis fixes record date for scheme of amalgamation Business Standard

Dishman buys Swiss pharma major Carbogen Business Standard